GoAI
Get started
Chemed Corporation logo

Chemed Corporation

CHE

NYSEHealthcareMedical - Care Facilities

Open in GoAI

Regular session

$541.63

+$1.06 · +0.20%

Aug 24, 2:00 PM ET

CHE company overview

Historical prices · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

47

Fair Value

Momentum

62

Gaining

Sentiment

63

Bullish

Risk resilience

83

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Kevin J. McNamara
Listed since
May 3, 1973
Employees
15,811

Market position

Day range

Current $541.63

52-week range

Current $541.63

Open
$541.79
Previous close
$540.57
Volume
50.32K
0.24× average
Average volume
208.92K
Average daily volume
Market cap
7.08B USD
Beta
0.51
Market reference 1
50-day average
$497.67
+8.83% above average
200-day average
$443.33
+22.17% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
6.24B USD
P/E (TTM)
27.19×
P/B (TTM)
8.75×
P/S (TTM)
2.73×
EV / EBITDA
14.78×
Earnings yield
4.31%
Free cash flow yield
5.28%
Dividend yield
0.46%

Profitability & efficiency

Gross margin
30.44%
Operating margin
13.46%
Net margin
10.60%
Return on equity
27.08%
Return on assets
16.17%
Return on invested capital
17.95%

Financial health

Debt / equity
0.4×
Current ratio
1.05×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends39%28%18%8%Gross margin, FY2021: 35.98%Gross margin, FY2022: 35.84%Gross margin, FY2023: 35.28%Gross margin, FY2024: 35.14%Gross margin, FY2025: 29.97%Operating margin, FY2021: 16.04%Operating margin, FY2022: 16.09%Operating margin, FY2023: 15.04%Operating margin, FY2024: 15.07%Operating margin, FY2025: 13.37%Net margin, FY2021: 12.55%Net margin, FY2022: 11.69%Net margin, FY2023: 12.03%Net margin, FY2024: 12.42%Net margin, FY2025: 10.48%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 35.98%. Gross margin FY2022 35.84%. Gross margin FY2023 35.28%. Gross margin FY2024 35.14%. Gross margin FY2025 29.97%. Operating margin FY2021 16.04%. Operating margin FY2022 16.09%. Operating margin FY2023 15.04%. Operating margin FY2024 15.07%. Operating margin FY2025 13.37%. Net margin FY2021 12.55%. Net margin FY2022 11.69%. Net margin FY2023 12.03%. Net margin FY2024 12.42%. Net margin FY2025 10.48%.

Income trends

Revenue

2.53B USD+4.06%

Operating income

338.25M USD-7.71%

Net income

265.24M USD-12.17%
Income trends across reported periods2.76B USD1.85B USD933.73M USD21.59M USDRevenue, FY2021: 2.14B USDRevenue, FY2022: 2.13B USDRevenue, FY2023: 2.26B USDRevenue, FY2024: 2.43B USDRevenue, FY2025: 2.53B USDOperating income, FY2021: 343.04M USDOperating income, FY2022: 343.5M USDOperating income, FY2023: 340.57M USDOperating income, FY2024: 366.49M USDOperating income, FY2025: 338.25M USDNet income, FY2021: 268.55M USDNet income, FY2022: 249.62M USDNet income, FY2023: 272.51M USDNet income, FY2024: 302M USDNet income, FY2025: 265.24M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.14B USD. Revenue FY2022 2.13B USD. Revenue FY2023 2.26B USD. Revenue FY2024 2.43B USD. Revenue FY2025 2.53B USD. Operating income FY2021 343.04M USD. Operating income FY2022 343.5M USD. Operating income FY2023 340.57M USD. Operating income FY2024 366.49M USD. Operating income FY2025 338.25M USD. Net income FY2021 268.55M USD. Net income FY2022 249.62M USD. Net income FY2023 272.51M USD. Net income FY2024 302M USD. Net income FY2025 265.24M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.53B USD2.43B USD2.26B USD2.13B USD2.14B USD
Cost of goods sold1.77B USD1.58B USD1.47B USD1.37B USD1.37B USD
Gross profit758.34M USD854.35M USD798.82M USD765.09M USD769.8M USD
Selling, general, and administrative417.19M USD424.36M USD395.12M USD358.73M USD366.73M USD
Operating expenses417.19M USD487.86M USD458.25M USD421.59M USD426.77M USD
Interest income8.75M USD14.61M USD6.27M USD355K USD377K USD
Interest expense1.75M USD1.78M USD3.11M USD4.58M USD1.87M USD
Depreciation and amortization64.84M USD63.05M USD60.87M USD59.17M USD59.05M USD
Operating income338.25M USD366.49M USD340.57M USD343.5M USD343.04M USD
Net income265.24M USD302M USD272.51M USD249.62M USD268.55M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
-0.74%
11 comparable reports
Latest EPS result
6.06
Estimate 5.6 · Beat by 8.21%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates7.36.25.093.99Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 6.83, estimate 6.78, surprise +0.74%, Beat. Q2 2025, reported Apr 23, 2025: actual 5.63, estimate 5.55, surprise +1.44%, Beat. Q3 2025, reported Jul 29, 2025: actual 4.27, estimate 4.78, surprise -10.67%, Miss. Q4 2025, reported Oct 28, 2025: actual 5.27, estimate 5.39, surprise -2.23%, Miss. Q1 2026, reported Feb 25, 2026: actual 6.42, estimate 7.02, surprise -8.55%, Miss. Q2 2026, reported Apr 23, 2026: actual 5.65, estimate 5.3, surprise +6.60%, Beat. Q3 2026, reported Jul 28, 2026: actual 6.06, estimate 5.6, surprise +8.21%, Beat. Q4 2026, reported Oct 27, 2026: actual —, estimate 6.48, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates711.89M671.73M631.57M591.42MQ1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 639.99M USD, estimate 636.1M USD, surprise +0.61%, Beat. Q2 2025, reported Apr 23, 2025: actual 646.94M USD, estimate 641.78M USD, surprise +0.80%, Beat. Q3 2025, reported Jul 29, 2025: actual 618.8M USD, estimate 631.15M USD, surprise -1.96%, Miss. Q4 2025, reported Oct 28, 2025: actual 624.9M USD, estimate 658.97M USD, surprise -5.17%, Miss. Q1 2026, reported Feb 25, 2026: actual 639.34M USD, estimate 659.09M USD, surprise -3.00%, Miss. Q2 2026, reported Apr 23, 2026: actual 657.51M USD, estimate 649.82M USD, surprise +1.18%, Beat. Q3 2026, reported Jul 28, 2026: actual 673.25M USD, estimate 665.04M USD, surprise +1.24%, Beat. Q4 2026, reported Oct 27, 2026: actual —, estimate 684.51M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$554

2.28% upside
Past 12 months12-month forecastHigh $633Average $554Low $475

CHE news

defenseworld.net

16,747 Shares in Chemed Corporation $CHE Purchased by Deutsche Bank AG

Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund…

Read source
businesswire.com

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE

NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an…

Read source
defenseworld.net

8,239 Shares in Chemed Corporation $CHE Acquired by Abacus FCF Advisors LLC

Abacus FCF Advisors LLC acquired a new stake in shares of Chemed Corporation (NYSE: CHE) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…

Read source
seekingalpha.com

Chemtrade Logistics Income Fund (CHE.UN:CA) Q2 2026 Earnings Call Transcript

Chemtrade Logistics Income Fund (CHE.UN:CA) Q2 2026 Earnings Call Transcript

Read source
globenewswire.com

Chemed Corporation Declares Quarterly Dividend of 70 Cents

CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable…

Read source
zacks.com

AVAH vs. CHE: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value…

Read source

ETFs holding CHE

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Mid-Cap ETF logoiShares Core S&P Mid-Cap ETFIJH
Market value
241.04M
Weight
0.19%
AUM
125.92B USD
Expense ratio
0.05%
Price / 1D
$76.04-0.95%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
227.46M
Weight
0.01%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$376.96-0.34%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
164.16M
Weight
0.09%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$302.31-0.80%
Vanguard Morningstar Small-Cap Growth ETF logoVanguard Morningstar Small-Cap Growth ETFVBK
Market value
94.45M
Weight
0.21%
AUM
43.8B USD
Expense ratio
0.05%
Price / 1D
$354.05-1.28%
First Trust SMID Cap Rising Dividend Achievers ETF logoFirst Trust SMID Cap Rising Dividend Achievers ETFSDVY
Market value
86.91M
Weight
0.74%
AUM
11.64B USD
Expense ratio
0.58%
Price / 1D
$43.865-0.01%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
81.37M
Weight
0.08%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$243.13-0.98%
Invesco S&P MidCap Quality ETF logoInvesco S&P MidCap Quality ETFXMHQ
Market value
59.87M
Weight
1.06%
AUM
5.67B USD
Expense ratio
0.31%
Price / 1D
$118.5-0.65%
State Street SPDR S&P MIDCAP 400 ETF Trust logoState Street SPDR S&P MIDCAP 400 ETF TrustMDY
Market value
52.45M
Weight
0.20%
AUM
26.72B USD
Expense ratio
0.23%
Price / 1D
$693.1-0.93%

Continue in GoAI

Research CHE

research.disclaimer